We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

19 hedge funds and large institutions have $54.1M invested in Xtant Medical Holdings in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

769% more capital invested

Capital invested by funds: $6.22M → $54.1M (+$47.8M)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

6% more funds holding

Funds holding: 1819 (+1)

17.53% less ownership

Funds ownership: 92.91%75.38% (-18%)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q4 2022 in Review

19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q4 2022, worth a combined $54.1M — up 769% from $6.22M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new XTNT positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $105K. The largest seller was Renaissance Technologies, cutting an estimated $13.7K.

  • 19 institutional investors held Xtant Medical Holdings (XTNT) as of Q4 2022, up from 18 in Q3 2022.
  • Funds reported $54.1M of Xtant Medical Holdings stock for Q4 2022, up 769% quarter-over-quarter.
  • 4 funds opened new Xtant Medical Holdings positions in Q4 2022 and 2 closed out, a net change of +2 holders.
  • The largest Xtant Medical Holdings buyer in Q4 2022 was Vanguard Group, an estimated $105K added.
  • The largest Xtant Medical Holdings seller in Q4 2022 was Renaissance Technologies, an estimated $13.7K sold.

Based on aggregated 13F filings for Q4 2022.